Best, C.H., AND Taylor, N.B.: The Physiological Basis of Medical Practice. The Williams and Wilkins Co., Baltimore, 1955 .
2.
Fulton, J.F. : Howell's Textbook of Physiology, W. B. Saunders Co., Philadelphia, 1946.
3.
Plotz, M.: Coronary Heart Disease. Paul B. Hoeber, Inc.New York, 1957.
4.
Raab, W.: Hormonal factors in heart disease: their role in myocardial hypertrophy, hypoxia and electrolyte imbalance. Ann. Int. Med., 41: 757, 1954.
5.
Raab, W.: Key position of catecholamines in functional and degenerative cardiovascular pathology. Am. J. Cardiol., 5: 571, 1960.
6.
Raab, W.: Hormonal and Cardiovascular Disorders. The Williams and Wilkins Co., Baltimore, 1953 .
7.
Raab, W.: The adrenergic-cholinergic control of cardiac metabolism and function . In: Advances of Cardiology, edited by R. Hegelein, Vol.1, p. 65. S. Karger, Basel-New York, 1956.
8.
Eckstein, R.W. , Stroud, M., Eckel , R., Dowling, C.V., AND Pritchard , W.H.: Effects of control of cardiac work upon coronary flow and oxygen consumption after sympathetic nerve stimulation. Am. J. Physiol., 163: 539, 1950 .
9.
Garcia-Ramos, J., AND De Arellano , J.R.: Los effectos de la adrenalina sobre el consumo de osigeno del corazon. Arch. Inst. cardiol. Mexico, 21: 205, 1951.
10.
Raab, W., AND Gigec, W.: Specific avidity of heart muscle to absorb and store epinephrine and norepinephrine . Circulation, 3: 553, 1955.
11.
Bloodworth, J.M.B., JR., AND Von Haam, E.: The tissue catecholamine concentration of the human heart, determined by the aluminum hydroxide-arsenomolybdic acid method. Circulation, 13: 573, 1956.
12.
Bing, R.J., Denforth, W.H., AND Ballard, F.B.: Physiology of the myocardium. J. A. M. A., 172: 438, 1960.
13.
Gazes, P.C. , Richardson, J.A., AND Woods, E.F.: Plasma catecholamine concentrations in myocardial infarction and angina pectoris. Circulation, 9: 657, 1959.
14.
Starcich, R. , AND Ambanelli, U.: Importanza della determinazione delle catecolamine plasmatiche in patologia coronarica. Gior. Clin. Med., 40: 1, 1959.
15.
Gorlin, R., Brachfeld, N., Messer, J.V., AND Turner, J.D.: Physiologic and biochemical aspects of the disordered coronary circulation . Ann. Int. Med., 51: 698, 1959.
16.
Price, R.K.: First effort angina, second wind in angina pectoris. Brit. Heart J., 13: 197, 1951.
17.
Cesarman, T. : Marsilid in the treatment of angina pectoris . J. Clin. Exper. Psychopath., 19 (suppl.): 169, 1958.
18.
Oblath, R.W. , AND Griffith, G.C.: Experiences in the treatment of angina pectoris with monoamine oxidase inhibitors . Presented at the Symposium on Current Topics in Cardiovascular Medicine, Washington, D. C., November 1960.
19.
Russek, H.I. : Monoamine oxidase inhibitors in the treatment of angina pectoris. Angiology, 11: 77, 1960.
20.
Finnerty, F.A.: MAO inhibitors and hypertension. Presented at the Symposium on Current Topics in Cardiovascular Medicine, Washington, D. C., November 1960.
21.
Gillespie, L., Terry, L.L., AND Sjoerdsma , A.: The application of monoamine oxidase inhibitor, 1-phenyl-2-hydrazinepropane (JB-516), to the treatment of primary hypertension. Am. Heart J., 58: 1959.
22.
Pletscher, A., AND Gey, K.F.: On the mechanism of action of monoamine oxidase inhibitors in angina pectoris . Presented at the Symposium on Current Topics in Cardiovascular Medicine, Washington, D. C., November 1960.